Almirall may acquire Bayer's dermatology unit
Almirall podría comprar el área dermatológica de Bayer
Intel ID : 240935
| Synopsis |
|
Almirall (BME:ALM), a Spain-based pharmaceutical, could be studying the acquisition of the dermatology unit of Bayer, based in Germany, for approximately EUR 1bn, reported El Economista on 24 September 2016, citing sources familiar. Bayer's aim would be to get liquidity for the acquisition of US-based Monsanto.
(content in spanish)
Almirall (BME: ALM), farmacéutica española, podría estar estudiando la compra del área de dermatología de la empresa alemana Bayer por aproximadamente EUR 1.000m, según ha informado El Economista el 24 de septiembre de 2016, basándose en fuentes cercanas a la operación. El objetivo de Bayer sería obtener liquidez para la compra de la compañía estadounidense Monsanto. |
| Intel ID | 240935 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Bayer
(31 Dec 2013) |
Revenue: EUR 40,16m EBITDA: EUR 7,83m |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 55.02.04 Pharmaceutical & Personal Care Chemicals 55 Raw Materials & Natural Resources / 55.02 Chemicals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.